It's a minor mystery in the drug world that's become a topic of debate among AstraZeneca (AZN)'s Symbicort sales staff: Why, in TV commercials for the asthma drug, is the presenter represented as a ...
AstraZeneca’s Don Apruzzese, formerly senior director of consumer marketing, is moving over to become regional commercial leader on the Symbicort for asthma launch, scheduled for mid-2007. In a world ...
LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
After seeing four of its patents for its Symbicort tossed aside, AstraZeneca has gained a key victory in defense of its blockbuster inhaler. A federal court in West Virginia upheld the company’s claim ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback